Efficacy and Safety of Sorafenib in Unresectable Hepatocellular Carcinoma with Bile Duct Invasion.

Abstract:

INTRODUCTION:Because the frequency of bile duct invasion in hepatocellular carcinoma (HCC) patients is very rare, there is limited clinical evidence to demonstrate the outcomes of systemic therapy in HCC with bile duct invasion. OBJECTIVE:Our aim was to clarify the efficacy and safety of sorafenib treatment in patients with unresectable advanced HCC with bile duct invasion. METHODS:One hundred and seventy-five patients with advanced HCC were enrolled in this study. We retrospectively compared the outcomes of sorafenib between patients without bile duct invasion [B (-) group, n = 165] and those with bile duct invasion [B (+) group, n = 10]. RESULTS:There were no significant differences in the confirmed objective response rate (ORR) and the confirmed disease control (DC) rate between the B (-) and the B (+) groups (13.9 vs. 20.0%, p = 0.637 for ORR; 47.2 vs. 70.0%, p = 0.202 for DC rate, respectively). There were no significant differences in median overall survival (OS) and time to progression (TTP) between the B (-) group and the B (+) group (14.8 vs. 14.1 months, p = 0.780 for OS; 3.4 vs. 5.7 months, p = 0.277 for TTP, respectively). Post-treatment factors associated with good OS were changes in albumin-bilirubin score (0-6 weeks) of <0.25, and antitumor response at 6 weeks of DC. Though 5 of 10 patients (50%) in the B (+) group had bile duct complications, such as obstructive jaundice and biliary bleeding, these 5 patients were able to recover from biliary troubles by careful and vigorous management with biliary endoscopic intervention, and were able to continue sorafenib therapy safely. CONCLUSIONS:Our present results suggest that sorafenib might have potential therapeutic efficacy and safety in advanced HCC patients with bile duct invasion. In case of biliary tract troubles before and during sorafenib treatment, early biliary management may be important to continue sorafenib therapy safely. Further studies are needed to confirm the outcomes of sorafenib in advanced HCC patients with bile duct invasion.

journal_name

Oncology

journal_title

Oncology

authors

Tanaka T,Kuzuya T,Ishigami M,Ito T,Ishizu Y,Honda T,Ishikawa T,Fujishiro M

doi

10.1159/000507051

subject

Has Abstract

pub_date

2020-01-01 00:00:00

pages

621-629

issue

9

eissn

0030-2414

issn

1423-0232

pii

000507051

journal_volume

98

pub_type

杂志文章

相关文献

ONCOLOGY文献大全
  • Hyperpyrexia, allergic-type response and death occurring with low-dose bleomycin administration.

    abstract::This is a case report of hyperpyrexia, shock and death following initial injection of low-dose bleomycin (7.5 units) for a poorly differentiated metastatic carcinoma. Premedication with high-dose dexamethasone and acetaminophen did not abort the reaction. A review of the literature uncovered one nearly fatal reaction ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225462

    authors: Levy RL,Chiarillo S

    更新日期:1980-01-01 00:00:00

  • Lipid metabolism and liver disease in hepatitis C viral infection.

    abstract::Persistent infection with hepatitis C virus (HCV) is a major risk toward development of hepatocellular carcinoma. A number of transgenic mouse lines carrying the cDNA of HCV genome have been established and evaluated in the study of HCV pathogenesis. Among those, the studies using transgenic mouse lines that carry the...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000315226

    authors: Koike K,Tsutsumi T,Yotsuyanagi H,Moriya K

    更新日期:2010-07-01 00:00:00

  • Effects of cycloheximide on chromatin-bound and -unbound PCNA in HeLa cells.

    abstract::We examined the effects of cycloheximide on the amount of chromatin-bound and -unbound PCNA subpopulations in HeLa cells. The chromatin-bound PCNA content decreased rapidly in the presence of cycloheximide, whereas the reduction of the total amount of PCNA was minimal even 24 h after the treatment with cycloheximide. ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227500

    authors: Sasaki K,Kurose A,Uesugi N,Kato A

    更新日期:1995-09-01 00:00:00

  • Evaluation of ART Scores for Repeated Transarterial Chemoembolization in Japanese Patients with Hepatocellular Carcinoma.

    abstract:OBJECTIVE:Transarterial chemoembolization (TACE) is recommended as a first-line therapy for hepatocellular carcinoma (HCC) patients ineligible for curative therapy and without portal invasion. The Assessment for Retreatment with TACE (ART) scoring system was recently proposed for identifying patients who would not show...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000440625

    authors: Arizumi T,Ueshima K,Iwanishi M,Minami T,Chishina H,Kono M,Takita M,Kitai S,Inoue T,Yada N,Hagiwara S,Ida H,Minami Y,Sakurai T,Nishida N,Kitano M,Kudo M

    更新日期:2015-01-01 00:00:00

  • Anticipatory nausea and vomiting: prevalence and predictors in chemotherapy patients.

    abstract::One hundred and seventy-five patients selected at random were prospectively studied. All patients were assessed at least after the first cycle of treatment by a self-report questionnaire which covered the occurrence of nausea and vomiting 24 before chemotherapy, as well as information regarding 22 clinical parameters....

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226675

    authors: Alba E,Bastus R,de Andres L,Sola C,Paredes A,Lopez Lopez JJ

    更新日期:1989-01-01 00:00:00

  • Long-term follow-up of patients with advanced ovarian carcinoma treated with debulking surgery and chemotherapy consisting of cisplatin, doxorubicin, and cyclophosphamide. Gynecologic Oncology Group of the Comprehensive Cancer Center.

    abstract::Between June 1980 and December 1984, 88 patients with stage III-IV ovarian carcinoma were entered in a study evaluating the role of debulking surgery and chemotherapy consisting of cyclophosphamide, doxorubicin, and cisplatin intravenously on day 1, every 4 weeks (CAP-1). The results after a median follow-up of 62 mon...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226801

    authors: Wils JA

    更新日期:1990-01-01 00:00:00

  • Inhibition of growth of Morris hepatomas 7777 and 7800 by corn oil.

    abstract::Intraperitoneal injection of trace amounts of corn oil prior to and following the injection of 40-50 mg of tissue from hepatoma 7777 or 7800 into the thigh of adult male Buffalo rats resulted in a marked decrease in the growth rate of both tumors. Exhaustive extraction of the corn oil with water indicated that the act...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225184

    authors: Gilbertson JR,Gelman RA,Ove P,Coetzee ML

    更新日期:1977-01-01 00:00:00

  • Histologic grade and cellular proliferation at the deepest invasive portion correlate with the high malignancy of submucosal invasive gastric carcinoma.

    abstract::To establish appropriate indications for endoscopic treatment of submucosal invasive gastric carcinoma, we investigated clinicopathologic features and proliferating cell nuclear antigen (PCNA) expression at the deepest invasive portion of 192 differentiated submucosal invasive gastric carcinomas that had been surgical...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227486

    authors: Nishida T,Tanaka S,Haruma K,Yoshihara M,Sumii K,Kajiyama G

    更新日期:1995-07-01 00:00:00

  • Inhibition of nitroso chemical carcinogen activation of rat hepatic guanylate cyclase by anticancer agents.

    abstract::Recent studies have demonstrated that nitroso chemical carcinogens activate guanylate cyclase (EC 4.6.1.2) which catalyzes the production of guanosine 3',5'-monophosphate. This nucleotide is thought to be involved in normal and abnormal cell growth. We examined the effect of 3 major classes of anticancer chemotherapeu...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225362

    authors: Vesely DL,Levey GS

    更新日期:1979-01-01 00:00:00

  • Phase II trial of alternating mFOLFOX6 and FOLFIRI regimens in the first-line treatment for unresectable or metastatic colorectal cancer (KSCC0701).

    abstract:OBJECTIVE:This phase II study examined the efficacy and safety of alternating regimens of mFOLFOX6 and FOLFIRI as a first-line treatment for unresectable or metastatic colorectal cancer. PATIENTS AND METHODS:Forty-eight patients were enrolled in this study. Patients received an alternating regimen of 4 cycles of mFOLF...

    journal_title:Oncology

    pub_type: 杂志文章,多中心研究

    doi:10.1159/000346690

    authors: Oki E,Emi Y,Akagi Y,Tokunaga S,Sadanaga N,Tanaka T,Ogata Y,Saeki H,Kakeji Y,Baba H,Nishimaki T,Natsugoe S,Shirouzu K,Maehara Y,Kyushu Study Group of Clinical Cancer.

    更新日期:2013-01-01 00:00:00

  • Perspectives in adjuvant therapy of gastric cancer.

    abstract::Although the incidence of gastric cancer has been declining in Western countries, it is still a major health problem and a leading cause of cancer mortality. Surgery is the mainstay of treatment for gastric adenocarcinoma. However, even among patients undergoing gastrectomy with curative intent, 5-year survival rates ...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000258494

    authors: De Vita F,Vecchione L,Galizia G,Di Martino N,Fabozzi T,Catalano G,Ciardiello F,Orditura M

    更新日期:2009-01-01 00:00:00

  • Phase-I clinical trial of sodium cyanate in patients with advanced colorectal carcinoma.

    abstract::Sodium cyanate, a drug that selectively suppresses amino acid incorporation for protein synthesis in tumor tissue, was given to patients with advanced colorectal carcinoma who had failed to conventional therapy, with the purpose of assessing a maximum tolerable oral dose. At 35 mg/kg p.o. daily, the drug had to be sto...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226038

    authors: Herrera-Ornelas L,Petrelli NJ,Madajewicz S,Mittelman A,Allfrey VG

    更新日期:1985-01-01 00:00:00

  • Acute gastroduodenal mucosal injury after cisplatin plus etoposide chemotherapy. Clinical and endoscopic study.

    abstract::The effects on gastric and duodenal mucosa induced by cisplatin plus etoposide (PE) chemotherapy were investigated in 32 patients with lung cancer. They were submitted to gastroduodenoscopy before receiving cisplatin 100 mg/m2 (day 1) plus etoposide at a mean dose of 107 mg/m2 (days 1, 3 and 5). Endoscopic examination...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226958

    authors: Sartori S,Nielsen I,Maestri A,Beltrami D,Trevisani L,Pazzi P

    更新日期:1991-01-01 00:00:00

  • Soluble tumor-associated markers in lung cancer extracts.

    abstract::Three lung tumor-associated markers (LTAM), previously identified as a Cohn Fraction IV alpha-globulin (LTAM-1), ferritin (LTAM-2) and lactoferrin (LTAM-3) were separated by a combination of ion exchange, dye-affinity and molecular sieve chromatography. They were further purified by polyacrylamide gel electrophoresis ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225542

    authors: Maxim PE,Veltri RW,Sprinkle PM

    更新日期:1981-01-01 00:00:00

  • Clinical relevance of sialyltransferases ST6GAL-I and ST3GAL-III in gastric cancer.

    abstract::Aberrant glycosylation of membrane components due to specific alterations of glycosyltransferase activity is a common feature of carcinoma cells and is usually associated with invasion and metastasis. In a prospective study, the enzyme activity of the sialyltransferases ST6GAL-I and ST3GAL-III was studied in gastric c...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000072339

    authors: Gretschel S,Haensch W,Schlag PM,Kemmner W

    更新日期:2003-01-01 00:00:00

  • Clear cell renal cell carcinoma associated with bilateral atypical acute posterior multifocal placoid pigment epitheliopathy.

    abstract:BACKGROUND/OBJECTIVE:Clear cell renal cell carcinoma (CCRCC) is a malignant neoplasm frequently associated with an increase in circulating immune complexes (CIC). Acute posterior multifocal placoid pigment epitheliopathy (APMPPE) is a disease involving the chorioretinal structures of the eye, and it is commonly observe...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000079505

    authors: Parmeggiani F,Costagliola C,D'Angelo S,Incorvaia C,Perri P,Sebastiani A

    更新日期:2004-01-01 00:00:00

  • The trophoblast theory of cancer (John Beard, 1857-1924) revisited.

    abstract::Beard's theory can be restated in a modified form in modern terms in the following way. Cancer represents primarily trophoblastic tissue derived either from an aberrant germ cell or from a somatic cell whose normally repressed 'asexual generation' genes are abnormally reactivated ('derepressed'). The variety of tumors...

    journal_title:Oncology

    pub_type: 传,历史文章,杂志文章

    doi:10.1159/000225037

    authors: Gurchot C

    更新日期:1975-01-01 00:00:00

  • Effect of 1(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU) on Sato lung carcinoma (SLC). Preliminary result of immunochemotherapy for SLC by combination of ACNU and Propionibacterium acnes.

    abstract::ACNU was highly effective for Sato lung carcinoma transplanted intravenously or intramuscularly by using a large single dose, and the cytotoxic action of ACNU for SLC showed clear dependence upon tumor size. Nonspecific activation of host-defence mechanism by Propionibacterium acnes contributed to the suppression for ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225309

    authors: Saijo N,Niitani H,Irimajiri N,Chikama M

    更新日期:1979-01-01 00:00:00

  • Localisation of Hodgkin's disease and lymphomas by 67-gallium substraction scanning.

    abstract::67Ga-subtraction scan was found to be useful and a promising new method for the pre-treatment evaluation of the patient with Hodgkin's disease or non-Hodgkin's lymphoma. The scan appeared to be most accurate in the neck, chest, and axillary regions. It appears to offer a means of increasing the accuracy of evaluating ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225217

    authors: Krolikiewicz H,Maruyama Y,Deland FH,Beihn RM,Hafner T,Utley JF

    更新日期:1977-01-01 00:00:00

  • Effects of theophylline treatment on mouse B-16 melanoma cells in vitro.

    abstract::The effects of theophylline treatment on mouse B-16 melanoma cell growth, metabolism, and membrane antigen expression in vitro were studied. Theophylline treatment inhibited DNA synthesis and the cell growth rate, and caused an elevation of intracellular cAMP levels. Cells treated with theophylline became elongated an...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225467

    authors: Kolb CA,Mansfield JM

    更新日期:1980-01-01 00:00:00

  • Open-Label Phase II Evaluation of Imatinib in Primary Inoperable or Incompletely Resected and Recurrent Glioblastoma.

    abstract:PURPOSE:Preclinical studies indicated that imatinib may have single-agent activity in glioblastoma through inhibition of tyrosine kinase activity and also that it might enhance the efficacy of radiotherapy. We therefore sought to investigate clinical efficacy in patients with newly diagnosed and recurrent glioblastoma ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000502483

    authors: Sautter L,Hofheinz R,Tuettenberg J,Grimm M,Vajkoczy P,Groden C,Schmieder K,Hochhaus A,Wenz F,Giordano FA

    更新日期:2020-01-01 00:00:00

  • Bile acid load on the DNA distribution pattern of bile ductules and cholangiocarcinoma induced by diisopropanolnitrosamine in hamsters.

    abstract::This study evaluated the influence of bile acid load on the DNA distribution pattern of proliferated bile ductules and cholangiocarcinoma induced by diisopropanolnitrosamine. Ninety hamsters were separated into control, tauro- and deoxycholic acid (DCA) groups. The DNA distribution pattern of intrahepatic lesions at 1...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000011839

    authors: Kinami Y,Miyakoshi M,Fujikawa K

    更新日期:1998-01-01 00:00:00

  • Presence of anti-gamma-FA-reactive antigens in spontaneous and carcinogen-induced malignancies of experimental animals.

    abstract::Immunochemical analysis of various tumors, representing 12 different tissue sites of origin, revealed a gamma-fetal antigen(gamma-FA)-like component in 17 of 23 malignant neoplasms of the mouse. This antigen was identified in extracts of spontaneous and carcinogen-induced murine tumors as well as in extracts of hepati...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225584

    authors: Higgins PJ,Tong C,Borenfreund E

    更新日期:1981-01-01 00:00:00

  • Human Telomerase Reverse Transcriptase Gene Promoter Mutation in Serum of Patients with Hepatocellular Carcinoma.

    abstract:BACKGROUND:Mutations in the human telomerase reverse transcriptase (hTERT) gene promoter have been reported in hepatocellular carcinoma (HCC); however, analyses of these mutations in liquid biopsies have been technically difficult because of the high GC content of the regions of interest within this promoter. We evalua...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000506135

    authors: Ako S,Nouso K,Kinugasa H,Matsushita H,Terasawa H,Adachi T,Wada N,Takeuchi Y,Mandai M,Onishi H,Ikeda F,Shiraha H,Takaki A,Fujioka S,Mimura T,Okada H

    更新日期:2020-01-01 00:00:00

  • A multicenter phase II randomized trial of docetaxel/gemcitabine versus docetaxel/capecitabine as first-line treatment for advanced breast cancer: a Gruppo Oncologico Italia Meridionale study.

    abstract:OBJECTIVE:To evaluate two docetaxel-based regimens as first-line treatment in advanced breast cancer patients. METHODS:Patients were randomly assigned to docetaxel/gemcitabine (arm A: docetaxel 75 mg/m(2) on day 1, gemcitabine 1,000 mg/m(2) on days 1 and 8) or docetaxel/capecitabine (arm B: docetaxel 75 mg/m(2) on day...

    journal_title:Oncology

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1159/000334432

    authors: Vici P,Giotta F,Di Lauro L,Sergi D,Vizza E,Mariani L,Latorre A,Pizzuti L,D'Amico C,Giannarelli D,Colucci G

    更新日期:2011-01-01 00:00:00

  • Prevalence of anemia in cancer patients undergoing radiotherapy: prognostic significance and treatment.

    abstract::As the antitumor activity of radiation is mediated via its interaction with oxygen to form labile free radicals, the intratumoral oxygen level has an important influence on the ability of radiation therapy to kill malignant cells. By decreasing the oxygen-carrying capacity of the blood, anemia may result in tumor hypo...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000067147

    authors: Harrison LB,Shasha D,Homel P

    更新日期:2002-01-01 00:00:00

  • Gemcitabine and cisplatin in refractory malignant lymphoma.

    abstract:OBJECTIVE:We performed a pilot study to evaluate the effect of the high-dose gemcitabine-cisplatin combination in a brief weekly regimen in the treatment of primary refractory diffuse large cell lymphoma with high or high-intermediate clinical risk. METHODS:Thirty patients refractory to first-line anthracycline-based ...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000077995

    authors: Avilés A,Neri N,Huerta-Guzmán J,Fernández R

    更新日期:2004-01-01 00:00:00

  • Characterization of vincristine-resistant HOB1 lymphoma cell line showing the classical MDR phenotype and altered expression of membrane glycoproteins.

    abstract::A multidrug-resistant (MDR) cell line isolated from HOB1 lymphoma cells was characterized. The MDR phenotype in this cell line was typified by resistance to vincristine with varying degrees of cross-resistance to Adriamycin, colcemid and actinomycin D. Decreased intracellular [3H]vincristine with concurrent increase i...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227300

    authors: Lee WP,Lee CL

    更新日期:1994-01-01 00:00:00

  • Concurrent chemoradiotherapy with a novel fluoropyrimidine, S-1, and cisplatin for locally advanced esophageal cancer: long-term results of a phase II trial.

    abstract:OBJECTIVES:A phase II study was performed to investigate the safety and efficacy of concurrent chemoradiotherapy (CCRT) combined with an orally active fluoropyrimidine, S-1, plus cisplatin for locally advanced esophageal cancer (LAEC). METHODS:CCRT comprised 2 courses, a 30-Gy radiotherapy over 3 weeks plus daily oral...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000348383

    authors: Iwase H,Shimada M,Tsuzuki T,Hirashima N,Okeya M,Hibino Y,Ryuge N,Yokoi M,Kida Y,Kuno T,Tanaka Y,Kato B,Esaki M,Urata N,Kato E

    更新日期:2013-01-01 00:00:00

  • Hand-Foot Syndrome and Post-Progression Treatment Are the Good Predictors of Better Survival in Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Multicenter Study.

    abstract:OBJECTIVE:To determine the relationship between treatment outcomes and hand-foot syndrome (HFS), and the relationship between survival rate and post-progression treatment after sorafenib therapy. METHODS:The study assessed 314 patients with advanced hepatocellular carcinoma (HCC) treated with sorafenib at 5 general ho...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000481241

    authors: Ogawa C,Morita M,Omura A,Noda T,Kubo A,Matsunaka T,Tamaki H,Shibatoge M,Tsutsui A,Senoh T,Nagano T,Takaguchi K,Tani J,Morishita A,Yoneyama H,Masaki T,Moriya A,Ando M,Deguchi A,Kokudo Y,Minami Y,Ueshima K,Sakur

    更新日期:2017-01-01 00:00:00